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Introduction: vitamin D affects the function of most of the cells in the body, including 
myocytes and endothelial cells, and also affects platelet function. This study aims to 
evaluate the relation between vitamin D deficiency and in-hospital and 6-month 
outcomes of patients with the acute coronary syndrome. 
Methods: This was a prospective cohort study of patients admitted to Mousavi hospital 
with the diagnosis of acute coronary syndrome. A venous blood sample obtained from 
patients at the time of admission and 25-hydroxyvitamin D, lipid profile, and hs-
troponin-I levels were measured. After coronary angiography, the severity of the 
coronary artery stenosis was calculated by the syntax score. Patients also evaluated in-
hospital outcomes and even followed up for 6-month results. 
Results: Totally, 204 patients were included in the study. The mean ± SD of age was 60 
± 11.6-year-old. The overall vitamin D deficiency was 80.9%. There was no association 
between vitamin D deficiency and in-hospital and 6-month mortality in patients with 
acute coronary syndrome (P = 0.824). There was a direct and statistically significant 
association between vitamin D levels and HDL cholesterol (P = 0.011). Twenty-eight 
percent of patients with negative hs-troponin-I and 14% with positive hs-troponin-I had 
normal vitamin D levels, which was statistically significant (P = 0.045). 
Conclusion: This study does not demonstrate an association between vitamin D levels 
and in-hospital and 6-month outcomes in patients with the acute coronary syndrome. 
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INTRODUCTION
Ischemic heart disease is one of the leading causes of 
death and disability among cardiovascular diseases [1]. 
Despite significant advances in the treatment and 
prevention of coronary artery disease, the rate of 
mortality and disability is still increasing [2]. Calcitriol 
or 25-hydroxyvitamin D (25[OH]D), an active form of 
vitamin D, affects the function of most of the cells in the 
body via its receptor (VDR), including myocytes and 
endothelial cells, as well as smooth muscle cells in the 
vasculature [3]. Vitamin D has anti-coagulant effects by 
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increasing the amount of thrombomodulin and 
reducing the tissue factor [4]. Also, vitamin D has an 
impact on platelet function, suppresses inflammatory 
processes, and suppresses the renin angiotensin system 
[5]. In recent years, several studies have examined the 
relationship between the level of vitamin D and 
cardiovascular disease and its mortality [6]. In some of 
these studies, there was a significant relationship 
between low serum vitamin D level and cardiovascular 
disease, while in others, this relationship has not been 
proven [7]. The association between vitamin D 
deficiency and risk factors for atherosclerosis, including 
obesity, hyperlipidemia, glucose intolerance, metabolic 
syndrome, and hypertension, has been proven [8, 9]. 
Few studies have been conducted on the association 
between levels of vitamin D and acute coronary 
syndrome with different results [4, 10]. Given the 
limited studies available and the contradictory results in 
this regard, we aimed to evaluate the relationship 
between serum vitamin D levels and the in-hospital and 
6-month outcomes in patients with the acute coronary 
syndrome. 
MATERIAL AND METHODS 
This study was a prospective, cohort study of all patients 
with acute coronary syndrome admitted in the cardiac 
care unit (CCU) in Mousavi hospital in Zanjan, 
between September 2016 and September 2017. The 
study was conducted under the principles of the 
declaration of Helsinki and approved by the ethics 
committee of Zanjan University of medical sciences 
(ZUMS.REC.1395.206). All the patients provided 
written informed consent. The inclusion criteria were: 
(1) age between 45-75 years; (2) patients with U.A 
(unstable angina), STEMI(S-T segment elevation 
myocardial infarction), or non-STEMI who underwent 
coronary angiography. The exclusion criteria were: (1) 
patients with the history of myocardial infarction; (2) 
patients with the history of CABG (coronary artery 
bypass graft) or PCI (percutaneous coronary 
intervention); (3) history of malignancy; (4) Patients 
undergoing dialysis; (5) Patients with a life expectancy 
of fewer than six months; (6) Lack of access to the 
patient during the follow-up. At the time of admission, a 
venous blood sample was obtained from the patients. 
The lab tests including 25[OH]D using ARCHITECT 
25-OH Vitamin D (Abbnott, USA), high sensitive 
Troponin-I using ARCHITECT STAT High Sensitive 
Troponin-I  (Abbnott, USA), blood glucose, lipid 
profile, and urine albumin to creatinine ratio were done. 
Regarding the manufacturer datasheet, the hs-troponin-
I levels more than 34.2 ng/ml in male patients and 15.6 
ng/ml in female patients were considered as positive. 
According to the vitamin D levels, Patients were divided 
into three groups: sufficient (vitamin D level ≥ 30 
ng/ml), mildly deficient (20 ng/ml ≤ vitamin D level < 
30 ng/ml), and severely inadequate (vitamin D level< 
20 ng/ml) [11]. The occurrence of arrhythmias, acute 
pulmonary edema, and mortality of the patients during 
admission, plus the data from the lab tests of the two 
groups, was recorded in the predesigned checklist. 
Angiographic data were calculated based on the syntax 
score. Two skilled cardiologists recalculated the syntax 
scores to confirm the accuracy of the results obtained 
from the first score calculation. The cardiologists were 
blinded to each other to calculate the syntax scores. 
Then patients were followed up for six months after the 
discharge. Patients’ follow up included their health 
status and re-hospitalization because of the acute 
coronary syndrome, arrhythmia, and mortality.  
Statistical Analysis 
All data were transferred into IBM SPSS statistics 
version 22 software and undergone statistical analysis. 
In data analysis, the Mann-Whitney test was used to 
compare the means of vitamin D and the occurrence of 
pulmonary edema and arrhythmias as early 
complications during admission, and re-hospitalization 
with cardiovascular causes as a late complication during 
six months. Chi-square test was used to determine the 
relationship between vitamin D level and HDL (high-
density lipoprotein) cholesterol, LDL (low-density 
lipoprotein) cholesterol, blood glucose, triglyceride, 
albumin to creatinine ratio, and also syntax score. Also, 
the Chi-square test was used to evaluate the variables, 
including hs-troponin-I status, pulmonary edema, and 
arrhythmia during hospitalization and re-hospitalization 
during six months in three groups of patients based on 
vitamin D level. Kruskal-Wallis test was used to 
determine the relationship between the severity of 
vitamin D deficiency with HDL cholesterol, LDL 
cholesterol, blood glucose, triglyceride, and albumin to 
creatinine ratio, as well as syntax score. The significance 
of the relationship was shown with the odds rate (95% 
CI). 
RESULTS 
Based on the inclusion criteria, a total of 257 consecutive 
ACS patients were included in the study. Thirty-eight 
patients due to lack of vitamin D samples, 13 patients 
due to lack of access to them for a six-month follow-up, 
and two patients due to malignancy were excluded from 
the study. Finally, data from 204 patients were analyzed. 
One hundred and fifty-four patients (75%) were men, 
and 50 (25%) were women. The mean ± SD of age was 
60 ± 11.6-year-old. The mean ± SD of vitamin D level 
was 22.57 ± 13.8 ng/ml. Of the 204 patients admitted 
with a diagnosis of acute coronary syndrome, 165 
patients (80.9%) suffered from vitamin D deficiency. Of 
these, 138 patients (83.6%) had a mild deficiency, and 
27 (16.4%) had severe lack. The baseline laboratory and 
angiographic results are shown in Table 1. The hospital 
course complications and follow up are shown in Table 
2. 
The Mann-Whitney test did not show a significant 
difference between two groups in terms of means of 
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vitamin D in men and women as well as hs-troponin-I 
status (P = 0.085 and P =0.204 respectively).  
 
Table 1. Demographic, Laboratory Results, and Syntax Score of the 
Patients 
 Values 
Age 60 ± 11.6 
Male Gender 154 (75) 
Risk Factors  
No 48 (23.5) 
Smoking 64 (31.3) 
HTNd 95 (46.5) 
DMe 63 (30.8) 
Vitamin D (ng/ml) 22.6 ± 13.8 
Triglyceride (mg/dl) 132.2 ± 73.6 
LDLa cholesterol (mg/dl) 88.9 ± 31.3 
HDLb cholesterol (mg/dl) 37.3 ± 9.9 
Blood glucose (mg/dl) 160.6 ± 81.8 
Albumin/Creatinine ratio 0.32 ± 1.09 
Syntax score 15.05 ± 9.53 
Positive Hs-troponin Ic 129 (63.2) 
Data in the table are presented as No. (%) or Mean ± SD. 
LDL: Low-density lipoprotein; HDL: High-density lipoprotein; Hs-
troponin I: High sensitive Troponin-I; HTN: Hypertension; DM: 
Diabetes Mellitus. 
 




Negative 182 (89.2) 
Atrial 10 (4.9) 
Ventricular 12 (5.9) 
Pulmonary edema 26 (12.7) 
Re-hospitalization 33 (16.2) 
In-hospital death 3 (1.5) 
Death during follow up 0 (0.0) 
Data in the table are presented as No.(%). 
 
Also, There was no significant difference between the 
vitamin D levels according to the occurrence of 
pulmonary edema, arrhythmias, re-hospitalization with 
cardiovascular causes (P = 0.305, P = 0.392, P = 985, 
respectively) (Table 3).There was a significant direct 
correlation between vitamin D and HDL cholesterol 
levels (P = 0.011). However, there was no meaningful 
relationship between vitamin D level and LDL 
cholesterol, blood glucose, triglyceride, albumin to 
creatinine ratio, and also syntax score (P > 0.05). In 
patients with negative hs-troponin-I (unstable angina), 
21 (28%) had sufficient vitamin D level, 46 (61.3%) 
were mildly deficient, and 8 (10.7%) were severely 
inadequate. In patients with positive hs-troponin-I 
(STEMI or non-STEMI), 18 (14%) had sufficient 
vitamin D level, 92 (71.3%) were mildly deficient, and 
19 (14.7%) were severely inadequate. There was a 
significant difference between the two groups (positive 
and negative hs-troponin-I) according to the vitamin D 
status (P = 0.045). The frequencies of the occurrence of 
the arrhythmia, pulmonary edema, and re-
hospitalization according to the vitamin D levels are 
shown in detail in Table 4. 
There were no significant differences between vitamin 
D status and the occurrence of arrhythmia and 
pulmonary edema (early complication) and re-
hospitalization (late complications) (P = 0.787, P = 
0.939, P = 0.961, respectively). The mean ± SD of 
Syntax score in the three groups according to the 
vitamin D status was 15.80 ± 11.75 ng/dl in the normal 
group, 14.92 ± 8.78 ng/dl in mildly deficient and 15.16 
± 9.68 ng/dl in severely small groups. There was no 
significant relationship between the severity of vitamin 
D deficiency with the calculated syntax score (P = 
0.939), as well as the other variables, including HDL 
cholesterol, LDL cholesterol, blood glucose, 
triglyceride, and albumin to creatinine ratio (P > 0.05) 
(Table 5). 
Of the patients studied, only 3 (1.5%) died during the 
hospitalization period. There was no significant 
relationship between vitamin D levels and the mortality 
during hospitalization period (P = 0.824). None of the 
patients died during six months follow up. 
 
 
Table 3. Comparison of Vitamin D level in Complicated and Non-complicated Patients during the Hospital Course and Six Months Follow Up 
 Vitamin D P-value 
 Mean ± SD a Median ± IQR b  
Hs-troponin-I   0.214 
Positive 21.16 ± 12.12 19.8 ± 12.2  
Negative 28.69 ± 16.13 20.4 ± 18.9  
Arrhythmia   0.392 
No 22.53 ± 14.13 19.7 ± 14.4  
Atrial 26.19 ± 12.3 21.8 ± 15.3  
Ventricular 20.08 ± 9.69 20.7 ± 11.7  
Pulmonary edema   0.305 
No 22.44 ± 14 19.7 ± 14.4  
Yes 23.45 ± 12.69 21 ± 10.3  
Re-hospitalization   0.985 
No 22.81 ± 14.3 19.8 ± 14.4  
Yes 21.31 ± 10.4 20.7 ± 13.8  
a, b Data in the table are presented as Mean ± Standard Deviation and Median ± Interquartile Range. 
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Table 4. Comparison of Severity of Vitamin D Deficiency in Complicated and Non-complicated Patients during the Hospital Course and six Months 
Follow Up. 
 Vitamin D P-value 
 Normal Mild deficiency Severe deficiency  
Hs-troponin-I    0.045 
Positive 18 (14) 92 (71.3) 19 (14.7)  
Negative 21 (28) 46 (61.3) 8 (10.7)  
Arrhythmia    0.787 
No 35 (19.2) 123 (67.6) 24 (13.2)  
Atrial 3 (30) 6 (60) 1 (10)  
Ventricular 1 (8.3) 9 (75) 2 (16.7)  
Pulmonary edema    0.939 
No 34 (19.1) 121 (68) 23 (12.9)  
Yes 5 (19.2) 17 (65.4) 4 (15.4)  
Re-hospitalization    0.961 
No 33 (19.3) 115 (67.3) 23 (13.5)  
Yes 6 (18.2) 23 (69.7) 4 (12.1)  
Data in the table are presented as No. (%). 
Hs-troponin-I: High sensitive troponin-I 
 
Table 5. Comparison of the Syntax Score and Laboratory Findings Based on the Severity of Vitamin D Deficiency 
 Vitamin D P-value 
 Normal Mild deficiency Severe deficiency  
 Mean ± SD a Median ± IQR b Mean ± SD Median ± IQR Mean ± SD Median ± IQR  
HDL (mg/dl) 38.95 ± 10.8 36 ± 12 37.34 ± 9.7 37 ± 13 34.74 ± 9.6 33 ± 7 0.253 
LDL (mg/dl) 83.31 ± 31.4 79 ± 54 89.75 ± 30.2 85 ± 42 93.52 ± 36.8 94 ± 58 0.457 
Triglyceride (mg/dl) 127.51 ± 84.6 105 ± 108 135.3 ± 70.6 120 ± 92 124.7 ± 74.5 113 ± 77 0.415 
BG (mg/dl) 144.6 ± 52.6 132 ± 75 158 ± 80.4 132 ± 76.5 199.2 ± 111 146 ± 140 0.162 
Syntax score 15.8 ± 11.75 15.5 ± 14.5 14.9 ± 8.78 14 ± 10 15.16 ± 9.68 12 ± 15.5 0.939 
Albumin/ Creatinine ratio 0.183 ± 0.17 0.128 ± 0.15 0.34 ± 1.3 0.137 ± 0.16 0.373 ± 0.56 0.18 ± 0.11 0.203 
a, b Data in the table are presented as Mean ± Standard Deviation and Median ± Interquartile Range.  
HDL: High-density lipoprotein; LDL: Low-density lipoprotein; BS: Blood Glucose. 
 
DISCUSSION 
In this study, 204 patients with the acute coronary 
syndrome, including acute myocardial infarction 
unstable angina, were evaluated. Finally, it was found 
that about 81% of patients had some degrees of Vitamin 
D deficiency. No significant relation observed between 
vitamin D level and variables such as hs-troponin-I 
status and short term outcomes. There was also a 
statistically significant correlation between the level of 
vitamin D and HDL cholesterol levels. Also, there was a 
significant difference between the hs-troponin-I and 
levels of vitamin D. 
In the study of the prevalence of vitamin D deficiency 
among patients with acute coronary syndrome, De 
Metrio et al. reported that about 70% of patients with 
the acute coronary syndrome had a mild deficiency, and 
19% had severe deficiency [5]. The results of this study 
were closely related to our results. In our study, patients 
had similar levels of vitamin D regardless of positive or 
negative hs-troponin-I levels. Correia et al. argued that 
levels of vitamin D did not correlate with hs-troponin-I 
levels [12]. As already mentioned, after dividing patients 
into three groups based on the vitamin D level, it was 
found that patients with negative hs-troponin-I are more 
likely to have normal levels of vitamin D. In other words, 
the rate of normal vitamin D level in patients with acute 
myocardial infarction is lower. These results suggest that 
the level of vitamin D in patients with acute coronary 
syndrome could be evaluated as an acute phase agent. 
Leong et al. reported that patients with normal levels of 
vitamin D had higher levels of hs-troponin-I [4]. The 
reason for this difference is probably due to the different 
methods of hs-troponin-I test, which in our study 
patients divided into two groups of positive and negative 
hs-troponin-I. Still, in the study of Leong, the hs-
troponin-I was expressed quantitatively. However, 
Naesgaard et al. found no relationship between vitamin 
D level and hs-troponin-I in patients with the acute 
coronary syndrome [13]. In our study, vitamin D level 
was not significantly associated with atrial fibrillation or 
ventricular arrhythmias. In a long-term follow-up study, 
it was found that atrial fibrillation was not associated 
with vitamin D levels [14]. But in a similar prospective 
study, vitamin D deficiency was significantly associated 
with atrial fibrillation in the long term follow up [8]. In 
a similar study with the present study, only one study 
examined vitamin D deficiency with the short-term and 
one-year outcomes of patients with acute coronary 
syndrome. It was found that during hospitalization, 
deficiency, or normal levels of vitamin D did not affect 
arrhythmias such as atrial fibrillation, ventricular 
tachycardia, and Brady-arrhythmias requiring 
pacemaker insertion [5]. One of the goals of this study 
was to examine the relationship between lipid profiles 
and vitamin D levels. In this study, there was a significant 
positive correlation between vitamin D levels and HDL 
cholesterol levels. The level of vitamin D was higher in 
those with high HDL cholesterol but did not show 
significant association when patients divided into three 
groups based on vitamin D level. There was no 
significant correlation between vitamin D and LDL 
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cholesterol and triglyceride. In various studies, the 
results are very different in this regard. In some studies, 
items of the lipid profile were significantly related to the 
vitamin D level, and in others, they were unrelated [15-
17]. The use of anti-lipid drugs, different timing for 
measuring lipid profile, and the different diet of the 
patients can explain these differences. Previous studies 
suggest that high blood sugar levels in patients with 
acute myocardial infarction are associated with worse 
clinical outcomes [18]. Also, it is reported that vitamin 
D deficiency is associated with insulin resistance [19]. 
Regarding this issue, another goal of this study was to 
investigate the relationship between non-fasting blood 
glucose and vitamin D levels, which did not showed 
significant correlation. However, in the study by Leong 
et al., It was reported that with increasing vitamin D 
levels, non-fasting blood glucose decreased significantly 
[4]. Albuminuria is one of the known risk factors for the 
development of cardiovascular diseases. On the other 
hand, vitamin D deficiency may interfere with the 
pathogenesis of protein excretion in the urine [20]. In a 
systematic review study, the use of an active form of 
vitamin D, along with other commonly used drugs, 
reduced the proteinuria in people with chronic kidney 
disease [21]. In our study, there was no significant 
correlation between albumin to urine creatinine ratio 
and vitamin D levels. One of the important goals of our 
study was to investigate the relationship between the 
level of vitamin D and the severity of coronary artery 
disease in patients with the acute coronary syndrome, 
which has been studied in various studies. In the 
Goleniewska study, the severity of coronary artery 
disease in patients with myocardial infarction was 
determined using the Gensini scoring system. Finally, 
there was no significant relationship between the 
severity of coronary artery disease and vitamin D levels 
[22]. De metrio et al. did not find a significant 
correlation between vitamin D level and syntax score in 
the outcome of patients with the acute coronary 
syndrome [5]. In our study, using the syntax scoring 
system, it was found that there was no statistically 
significant correlation between the severity of coronary 
involvement and vitamin D levels. However, Dziedzic et 
al. showed a significant relationship between the severity 
of the coronary involvement and vitamin D levels, using 
the CASSS scoring system [23]. The type of study 
design, target population, and the difference in the 
systems for calculating the severity of coronary artery 
involvement could be the probable causes of the 
difference in the results of various studies. In this study, 
three patients died during admission, and 27 patients 
with a mean vitamin D level of 20 ng/dl were re-
hospitalized. However, vitamin D levels did not 
significantly correlate with mortality and re-
hospitalization. So far, several studies have been 
conducted on the relationship between vitamin D and 
cardiovascular death and But there is no cohesion in the 
results of studies. A systematic review by Miller et al. 
concluded that vitamin D levels ranging from 15 to 70 
ng/dl had no relation to increased cardiovascular 
mortality [24]. But De metrio et al. showed that there is 
a significant relationship between vitamin D level and 
hospitalization mortality and re-hospitalization [5]. 
Also, Correia et al. also argued that in-hospital deaths in 
patients with vitamin D deficiency are higher than those 
with normal levels of vitamin D [12]. Small sample size, 
exclusion of patients with previous history of myocardial 
infarction and entry of patients with a maximum age of 
75 years were the notable differences with the two 
studies mentioned, which can reduce the relative 
mortality in our subjects and could be an explanation for 
the lack of relevance of vitamin D levels to the mortality 
and re-hospitalization. 
Limitations 
The major limitation of this study was that due to the 
small study population, mortality, as an essential 
cardiovascular outcome did not occur during six 
months, follow up and the statistical analysis could not 
be done for this variable. Also, the results regarding the 
in-hospital mortality cannot be reliable as the result of 
low incidence. 
CONCLUSION 
In conclusion, the results of this study showed that a 
large proportion of patients with the acute coronary 
syndrome, especially those with acute myocardial 
infarction, suffer from vitamin D deficiency. The studies 
that have been conducted so far on the relationship 
between vitamin D levels and short and long-term 
complications of the acute coronary syndrome have also 
shown controversial results. The present study did not 
show a significant correlation between vitamin D levels 
and in-hospital and 6-month implications of patients 
with the acute coronary syndrome. Further studies are 
suggested to evaluate the relevance of vitamin D levels 
with some factors such as coronary calcification, lesion 
length, etc. Also, in future studies, longer follow-up and 
vitamin D testing at different intervals is recommended 
to ensure that the serum vitamin D levels remain stable. 
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